Targeting B-cell malignancies with ?-specific T cells can lead to complete clinical responses

Posted by on June 7, 2016 12:01 am
Categories: health

Targeting the light chain expressed by malignant B cells killed tumor cells while sparing normal B cells expressing the other type of light chain, report researchers at conclusion of a recent study.

Leave a Reply

Your email address will not be published. Required fields are marked *